preliminary trials
More News
-
China optimises treatment for COVID-19
Tocilizumab, with the common brand name Actemra, has been included in China's latest version of diagnosis
FOLLOW US
This material may not be published, broadcast, rewritten, redistributed or derived from. Unless otherwise stated, all content is copyrighted © 2024 The Express Tribune.